Silk Fibroin-Based Fibrous Anal Fistula Plug with Drug Delivery Function.

Author: HanZhifen, KaplanDavid L, LiGang, LiuLei, WangXiaoqin, XieXusheng, ZhengZhaozhu, ZhiMin

Paper Details 
Original Abstract of the Article :
The aim of this work is to develop a drug-loaded silk fibroin fibrous membrane (DSFM) that can be attached to the surface of an anal fistula plug to improve the treatment of Crohn's disease (CD). Curcumin (CUR) and 5-aminosalicylic acid (5-ASA)-loaded silk fibroin (SF) membranes are coaxially electr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/mabi.201700384

データ提供:米国国立医学図書館(NLM)

Silk Fibroin: A Natural Solution for Crohn's Disease

Crohn's disease, a chronic inflammatory bowel disorder, can be a challenging condition to manage. It's like a persistent desert wind, creating havoc in the digestive system.

This research explores the potential of a silk fibroin-based fibrous anal fistula plug loaded with drugs to improve treatment outcomes for Crohn's disease. Silk fibroin, a protein derived from silk, is known for its biocompatibility and its ability to promote tissue regeneration. The researchers developed a dual-drug-loaded silk fibroin fibrous membrane (DSFM) that can be attached to the surface of an anal fistula plug. This innovative approach aims to deliver curcumin (CUR) and 5-aminosalicylic acid (5-ASA), both known for their anti-inflammatory properties, directly to the affected area.

The DSFM exhibited a unique core-shell structure, allowing for controlled and sustained release of the encapsulated drugs. The researchers optimized the drug loading concentration to maximize effectiveness while ensuring biocompatibility. In vitro studies demonstrated that the DSFM exhibited no cytotoxicity and promoted fibroblast growth, suggesting its potential for tissue regeneration.

Silk Fibroin: A Promising New Tool in the Fight Against Crohn's Disease

This research presents a promising new approach to treating Crohn's disease. The DSFM, with its unique dual-drug delivery system and biocompatible properties, could potentially improve treatment outcomes by reducing inflammation and promoting tissue healing.

Navigating the Desert of Crohn's Disease: Seeking New Avenues

The journey through Crohn's disease can be long and challenging. This research offers a potential beacon of hope, highlighting the potential of silk fibroin-based technologies in developing innovative treatment strategies.

Dr. Camel's Conclusion

This research opens up a new and exciting avenue in the treatment of Crohn's disease. The DSFM, with its targeted drug delivery and tissue regeneration properties, could provide a much-needed solution for individuals suffering from this chronic inflammatory bowel disorder. It's like finding a hidden oasis in the desert, offering a renewed sense of hope and possibility.
Date :
  1. Date Completed 2019-02-01
  2. Date Revised 2019-02-01
Further Info :

Pubmed ID

29411947

DOI: Digital Object Identifier

10.1002/mabi.201700384

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.